BNP Paribas Exane Adjusts Price Target on Xylem to $153 From $166, Keeps Outperform Rating
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.42 USD | +1.24% |
|
+7.91% | +13.27% |
Feb. 06 | Trane Technologies Appoints Matthew Pine as Board of Directors, Effective April 1, 2025 | CI |
Feb. 05 | Baird Adjusts Price Target on Xylem to $148 From $139 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration